Gene · 3398
Papers4,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer. | Front Genet | 2022 | 36685879 | PubTator, text mining | PubMed |
| Disordered T cell-B cell interactions in autoantibody-positive inflammatory arthritis. | Front Immunol | 2022 | 36685593 | PubTator, text mining | PubMed |
| Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis. | Front Immunol | 2022 | 36685500 | PubTator, text mining | PubMed |
| Messenger roles of extracellular vesicles during fertilization of gametes, development and implantation: Recent advances. | Front Cell Dev Biol | 2022 | 36684431 | PubTator, text mining | PubMed |
| Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. | Genes (Basel) | 2022 | 36672796 | PubTator, text mining | PubMed |
| Application of Single-Cell RNA Sequencing in Ovarian Development. | Biomolecules | 2022 | 36671432 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer. | Ann Transl Med | 2022 | 36660722 | PubTator, text mining | PubMed |
| Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. | Cancer Drug Resist | 2022 | 36627902 | PubTator, text mining | PubMed |
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review. | Cancer Drug Resist | 2022 | 36627894 | PubTator, text mining | PubMed |
| Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods. | Front Oncol | 2022 | 36620585 | PubTator, text mining | PubMed |
| New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter? | Int J Mol Sci | 2022 | 36613878 | PubTator, text mining | PubMed |
| Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma. | Int J Mol Sci | 2022 | 36613587 | PubTator, text mining | PubMed |
| Single-Cell and CellChat Resolution Identifies Collecting Duct Cell Subsets and Their Communications with Adjacent Cells in PKD Kidneys. | Cells | 2022 | 36611841 | PubTator, text mining | PubMed |
| Embryonic ILC-poiesis across tissues. | Front Immunol | 2022 | 36605193 | PubTator, text mining | PubMed |
| Biology and clinical relevance of follicular cytotoxic T cells. | Front Immunol | 2022 | 36591286 | PubTator, text mining | PubMed |
| Expression profiles of small non-coding RNAs in breast cancer tumors characterize clinicopathological features and show prognostic and predictive potential. | Sci Rep | 2022 | 36585466 | PubTator, text mining | PubMed |
| Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications. | Front Immunol | 2022 | 36569873 | PubTator, text mining | PubMed |
| The Theory of Carcino-Evo-Devo and Its Non-Trivial Predictions. | Genes (Basel) | 2022 | 36553613 | PubTator, text mining | PubMed |
| Identification of the Transcriptional Regulatory Role of RUNX2 by Network Analysis in Lung Cancer Cells. | Biomedicines | 2022 | 36551878 | PubTator, text mining | PubMed |
| How Well Do Rodent Models of Parkinson's Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review. | Biomedicines | 2022 | 36551782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3398/papers?page=26